Madrigal Pharmaceuticals ... (MDGL)
315.10
-26.17 (-7.67%)
At close: Mar 03, 2025, 3:59 PM
Madrigal Pharmaceuticals Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY01 |
| Cash & Equivalents | 100.02M | 99.92M | 331.55M | 36.27M | 54M | 46.7M | 483.72M | 191.53M | 40.5M | 34.97M | 46.02M | 48.49M | 81.51M | 30.07M | 31.31M | 44.16M | 52.05M | 115.58M | 33.69M | 23.81M | 42.74M | 36.06M | n/a |
| Short-Term Investments | 826.23M | 534.22M | 27.23M | 234.08M | 230.15M | 392.35M | 426.34M | 42.9M | 21.35M | 31.61M | 51.67M | 42.99M | 19.09M | 9.65M | 19.66M | n/a | 21.52M | n/a | 13.14M | 38.25M | 82.23M | 40.16M | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 54.00 | n/a | 305K | 1.41M | 458K | 631K | 366K | 358K | 103K | 76K | 1.09M | 133K | 1.2M | 82K | n/a |
| Receivables | 53.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.33K | n/a | n/a | n/a | n/a | 116K | n/a | 16M | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | 34.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.33K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 18.79M | 3.15M | 2.6M | 2.68M | 2.03M | 2.3M | 2.97M | 970K | 707K | 50K | 1.66M | 1.53M | 1.57M | 1.12M | 431K | 838K | 1.66M | 1.42M | 803K | 893K | 1.05M | 834K | n/a |
| Total Current Assets | 1.03B | 637.28M | 361.37M | 271.68M | 285.16M | 440.2M | 485.2M | 192.01M | 41.21M | 67.78M | 99.35M | 92.24M | 101.39M | 40.29M | 51.52M | 44.57M | 91.22M | 117M | 47.63M | 62.95M | 126.02M | 77.06M | n/a |
| Property-Plant & Equipment | 4.59M | 3.27M | 1.2M | 1.65M | 1.83M | 1.86M | 227K | 301K | 2.95K | 420K | 1.02M | 1.55M | 1.17M | 1.41M | 2.18M | 3.98M | 5.93M | 5.58M | 6.07M | 8.13M | 4.8M | 3.25M | n/a |
| Goodwill & Intangibles | 4.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 9.32M | 3.27M | 1.2M | 1.65M | 1.83M | 1.86M | 227K | 301K | 3K | 420K | 1.33M | 2.96M | 1.63M | 2.04M | 2.55M | 4.34M | 6.03M | 5.65M | 7.16M | 8.26M | 6M | 3.33M | n/a |
| Total Assets | 1.04B | 640.55M | 362.57M | 273.33M | 287M | 442.06M | 485.43M | 192.31M | 41.21M | 68.19M | 100.67M | 95.2M | 103.02M | 42.32M | 54.07M | 48.91M | 97.25M | 122.65M | 54.79M | 71.21M | 132.02M | 80.39M | 2.77M |
| Account Payables | 43.6M | 28.04M | 23.83M | 21.38M | 1.02M | 1.18M | 2.49M | 1.93M | 762K | 102.29K | 3.14M | 6.59M | 5.66M | 3.47M | 1.93M | 3.96M | 3.33M | 2.49M | 2.63M | 3.36M | 2.88M | 209K | n/a |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -43K | -42K | -42K | -13K | -12K | 4.57M | 4.65M | 12.59M | 5.35M | 457K | 457K | 457K | 345K | n/a |
| Short-Term Debt | 1.97M | 527K | 602K | 820K | 636K | 630K | n/a | n/a | n/a | 48.6M | 9.26M | 9.54M | 7.95M | 4.25M | 201K | 1.26M | 4.34M | 2.41M | 2.33M | 1.92M | 537K | n/a | n/a |
| Other Current Liabilities | 123.71M | 89.98M | 91.46M | 54.64M | 44.9M | 23.32M | 5.96M | 8.13M | 4.04M | 579.48K | 18.49M | 16.08M | 9.88M | 7.43M | 10.04M | 6.6M | 13.06M | 10.53M | 6.13M | 8.74M | 9M | 2.94M | n/a |
| Total Current Liabilities | 169.28M | 118.55M | 115.89M | 76.84M | 46.56M | 25.13M | 8.44M | 10.05M | 4.8M | 17.79M | 30.89M | 32.21M | 23.49M | 15.15M | 16.74M | 16.47M | 33.32M | 20.77M | 11.55M | 14.47M | 12.88M | 3.5M | n/a |
| Long-Term Debt | 1.02M | 116.67M | 49.29M | 387K | 468K | 361K | n/a | n/a | n/a | n/a | 4.65M | 13.9M | 4.46M | 12.4M | 11.69M | 799K | 8.31M | 2.81M | 3.17M | 4.26M | 1.19M | n/a | n/a |
| Other Long-Term Liabilities | 117.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 41.82M | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 118.59M | 116.67M | 49.29M | 387K | 468K | 361K | n/a | n/a | n/a | n/a | 4.65M | 13.9M | 4.46M | 12.4M | 13.85M | 7.53M | 122.72M | 76.98M | 44.99M | 4.26M | 1.19M | n/a | n/a |
| Total Liabilities | 287.86M | 235.21M | 165.18M | 77.22M | 47.02M | 25.49M | 8.44M | 10.05M | 4.8M | 17.79M | 35.54M | 46.11M | 27.95M | 27.55M | 30.59M | 24M | 156.04M | 97.75M | 56.54M | 18.73M | 14.06M | 3.5M | 29K |
| Total Debt | 983K | 117.19M | 49.89M | 797K | 786K | 676K | n/a | n/a | n/a | 4.65M | 13.91M | 23.4M | 12.4M | 16.65M | 11.89M | 2.06M | 10.48M | 5.22M | 5.5M | 6.17M | 1.73M | n/a | n/a |
| Common Stock | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 1K | 1.2K | 14K | 11K | 9K | 7K | 5K | 4K | 3K | 3K | 3K | 2K | 2K | 3K | 3K | 1K |
| Retained Earnings | -1.8B | -1.34B | -962.66M | -667.31M | -425.46M | -223.22M | -139.27M | -106.46M | -75.31M | -706.24M | -637.57M | -551.41M | -461.22M | -398.43M | -351.05M | -313.58M | -392.67M | -300.05M | -236.56M | -179.29M | -110.42M | -64.49M | n/a |
| Comprehensive Income | 468K | 468K | -32K | -80K | 47K | 216K | -319K | -31K | 25.4K | 4K | 4K | 17K | 2K | 3K | -3K | -16.03M | 15K | -11.52M | 2K | -7.27M | -10.55M | -2.77M | n/a |
| Shareholders Equity | 754.38M | 405.33M | 197.39M | 196.11M | 239.97M | 416.56M | 476.98M | 182.26M | 36.41M | 50.41M | 65.14M | 49.09M | 75.07M | 14.77M | 23.48M | 24.91M | -58.79M | 24.9M | -1.75M | 52.48M | 117.96M | 76.89M | 2.74M |
| Total Investments | 826.23M | 534.22M | 27.23M | 234.08M | 230.15M | 392.35M | 426.34M | 42.9M | 21.35M | 31.61M | 51.67M | 42.99M | 19.09M | 9.65M | 19.66M | n/a | 21.52M | n/a | 13.14M | 38.25M | 82.23M | 40.16M | n/a |